Stroke rehabilitation in adults

more likely to improve with treatment aimed at a specific area of the body. Most of the available evidence was on focal spasticity, particularly of the upper limb. Spasticity can be difficult to treat, so it is important that people after stroke, and their families and carers, are given information on the condition. This will help ensure they know when to seek help but also to understand that spasticity is a difficult condition to manage. The multidisciplinary stroke rehabilitation team should also be involved in individual plans for managing focal and generalised spasticity. Based on their experience, the committee also highlighted some interventions that have been widely used for a long time, for example, stretches or advice on how to avoid triggers. For focal spasticity, the committee looked at the evidence for different types of botulinum toxin A, including Dysport, Botox and Xeomin. Dysport and Xeomin were found to be both cost effective and beneficial in terms of both reducing spasticity in the upper limb and improving activities of daily living. However, Dysport and Xeomin were only cost effective if certain doses were given and if: • the injections were spread across multiple points in the affected limbs and •
